+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Penile Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Pre Book Price: $ 5216

Original Price: $ 5795

Cancer, according to the International Agency for Research on Cancer (IARC) resulted in the death of around 4.6 million men worldwide in 2012. Around 14% of the world’s total annual deaths are as a result of various cancers. Modern medicine has extended the life expectancy of a cancer patient by a great margin. However newer cases are diagnosed every year globally, the present rate stands at 7.4 million newly diagnosed males annually, according to the WHO. This is commonly as a result of the changing lifestyles, unhealthy diet, hereditary factors and exposure to carcinogenic elements, cigarette smoking, etc. Male specific cancers include: prostate cancer, testicular cancer, and penile cancer. Among which prostate cancer is the most prevalent form of male cancer. Male specific cancers are generally benign/malignant tumors that rarely undergo metastasis. 
Penile cancers are an even rarer form of cancer specific to the male reproductive organ i.e. penis, but unlike prostate and testicular cancer, they are commonly as a result of human papiloma virus (HPV), and human immunodeficiency virus (HIV) infection. According to the U.S National Cancer Institute study roughly 40% of all penile cancer is as a result of HPV infections, whereas HIV patients exhibit eight time increased risk of penile cancer. Hence penile cancer rates are high in developing countries of Africa, South Asia and South America. This is probably why vaccination for HPV virus (Gardasil or Cervarix) is regarded by a share of expert medical practitioners as a preventive measure in decreasing penile cancer rates globally. The incidence rate for penile cacner is found higher in men above 30 years of age,   Penile cancer is majorly categorized as squamous cell carcinoma, as a large majority of penile cancer patients have exhibited this form. Other even rare types include intraepithelial neoplasia, bowenoid papulosis and invasive carcinoma of the penis. 
The diagnosis of penile cancer is initially done by physical examination of the penis, this is followed by the biopsy of the outgrowth i.e. wart/ papules or skin abscess. Staging of the penile malignancy is done further to establish a timeline of disease progression. Chemotherapy, antiviral therapy and surgical excision are the common mode of treatment for penile cancer. Surgical methods are classified on the type of procedure apt to remove the tumor; circumcision, microsurgery, excision, or penectomy (castration) are the generally followed procedures. Radiation is used to prevent any reoccurrence, although the procedure can render the patient infertile. 
That said, the market for male cancer therapeutics is highly fragmented hence not easily quantifiable, however the surgery and overall treatment market remains in millions of USD, with new  diagnostic screening procedures and drug combinations being patented every year, each having their own market segment. With entry of Asian players the prices too are bound to decrease, thereby potentially increasing the overall therapeutics market. 
The North American market is the highest market by volume, followed by Europe, as in these regions the number of reported cases are high in number, and so is the affordability of drugs. In developing markets of Asia and South America, their poor hygiene standards, presence of a large HIV patient population along with their overall increasing population size make for a large market, however unavailability of affordable diagnostic procedures and therapeutic drugs is thought to be the major reason why diagnosis is few in number and why the markets haven’t been proliferated as of yet. The rest of the world region is also bound to follow a similar pattern with increased awareness and diagnostic rates, the number of diagnosed individuals undergoing therapy in this region is however very small.
Some of the major companies manufacturing HPV vaccines include: GlaxoSmithKline PLC, Novartis AG, MercK & Co, etc to name a few.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments

Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top